Cited by

• Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

  Mauguen A, Le Péchoux C, Saunders MI, Schild SE, Turrisi AT, Baumann M, Sause WT, Ball D, Belani CP, Bonner JA, Zajusz A, Dahlberg SE, Nankivell M, Mandrekar SJ, Paulus R, Behrendt K, Koch R, Bishop JF, Dische S, Arriagada R, De Ruysscher D, Pignon JP. Mauguen A, et al. J Clin Oncol. 2012 Aug 1;30(22):2788-97. doi: 10.1200/JCO.2012.41.6677. Epub 2012 Jul 2. J Clin Oncol. 2012. PMID: 22753901 Free PMC article.
• The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer.

  Holgersson G, Bergqvist M, Nyman J, Hoye E, Helsing M, Friesland S, Holgersson M, Ekberg L, Mörth C, Ekman S, Blystad T, Ewers SB, Löden B, Henriksson R, Bergström S. Holgersson G, et al. Med Oncol. 2013 Mar;30(1):320. doi: 10.1007/s12032-012-0320-y. Epub 2012 Dec 18. Med Oncol. 2013. PMID: 23254960
• Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials.

  Liu Y, Kou C, Su Y, Zhang Y, You Y, Zhang L, Wang M, Fu Y, Ren X, Yang Y. Liu Y, et al. Onco Targets Ther. 2017 Jun 13;10:2971-2981. doi: 10.2147/OTT.S137474. eCollection 2017. Onco Targets Ther. 2017. PMID: 28652779 Free PMC article.
• Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends.

  Maciejczyk A, Skrzypczyńska I, Janiszewska M. Maciejczyk A, et al. Rep Pract Oncol Radiother. 2014 Jul 17;19(6):353-60. doi: 10.1016/j.rpor.2014.04.012. eCollection 2014 Nov. Rep Pract Oncol Radiother. 2014. PMID: 25337407 Free PMC article. Review.
• 18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.

  Ford EC, Herman J, Yorke E, Wahl RL. Ford EC, et al. J Nucl Med. 2009 Oct;50(10):1655-65. doi: 10.2967/jnumed.108.055780. Epub 2009 Sep 16. J Nucl Med. 2009. PMID: 19759099 Free PMC article. Review.